Genomic DNA extraction was performed on the basis of the manufacturer’s procedures of GoldMag Beads DNA Extraction Kit (GoldMag, Xi’an, Shaanxi, China). DNA concentration was determined by Spectrometry (Beckman Instruments, Fullerton, CA, USA).
Agena MassARRAY platform (Agena Bioscience, San Diego, CA, USA) was utilized for SNP genotyping. The design of extended primers was conducted by the Agena online design software (
https://agenacx.com/online-tools/), and the sequences were listed in Supplementary Table
1. The process of genotyping was double-blinded by two laboratory personnel. For quality control, 10% of the samples were randomly chosen for repeated genotyping, and the reproducibility was 100%.
All seven candidate SNPs in
CYP19A1 (rs4646, rs6493487, rs1062033, rs17601876 and rs3751599) and
CYP1A2 (rs762551 and rs2470890) were screened using the database of dbSNP in NCBI and the 1000 Genomes Project data, and the selection criteria were as follows: i) the minor allele frequency (MAF) of all SNPs was greater than 5%; ii) call rate was over 95% during genotyping; iii) r
2, a pairwise linkage disequilibrium (LD), was over 0.8. Besides, we applied RegulomeDB annotations to predict the effect of these SNPs according to the rank score evaluated by a model integrating functional genomic features.
Yang Y, & Wang P. (2020). Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population. Lipids in Health and Disease, 19, 187.